eiden Improvement of MIgraine Therapy in general practice

Completed

• Conditions: Nervous System Diseases; Episodic and paroxysmal disorders; Migraine

• Registration Number: ISRCTN72421511
• Lead Sponsor: eiden University Medical Center (LUMC) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-22
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

Patients in general practice using more than or equal to 24 Defined Daily Doses (DDD) triptans (or more than or equal to six DDDs in the last three months), enlisted in 60 general practices, that are part of LEON (Leiden Eerstelijns OnderzoeksNetwerk), managed by the department of Public Health and Primary Care.

Exclusion Criteria

1. Younger than 18 years
2. Cognitive impairment
3. Psychiatric illness
4. Terminal illness
5. Non-Dutch speaking

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Headache Impact Test (HIT-6) score at baseline and after three, six, nine and 12 months.

Secondary Outcome Measures

Name	Time	Method
1. The health-related quality of life (self reported EuroQoL [EQ-5D] questionnaire and visual analogue scale)<br>2. Migraine characteristics<br>3. Medication use<br>4. Social effects of migraine including absence at work<br><br>Measured at baseline and after three, six, nine and 12 months.